IGC Pharma Inc (AMEX:IGC) shares, rose in value, with the stock price down by -9.04% to the previous day’s close as strong demand from buyers drove the stock to $0.38.
Actively observing the price movement in the recent trading, the stock is buoying the session at $0.41, falling within a range of $0.37 and $0.3934. The value of beta (5-year monthly) is 1.479. Referring to stock’s 52-week performance, its high was $0.50, and the low was $0.25. On the whole, IGC has fluctuated by 22.09% over the past month.
With the market capitalization of IGC Pharma Inc currently standing at about $31.67 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Jun-27.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 1.45M, with a low estimate of 326k and a high estimate of 326k. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 326k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that IGC’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of IGC currently trading nearly 18.67% and 20.82% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 66.61, while the 7-day volatility ratio is showing 14.36% which for the 30-day chart, stands at 6.23%. Furthermore, IGC Pharma Inc (IGC)’s beta value is 1.47.
A comparison of IGC Pharma Inc (IGC) with its peers suggests the former has fared considerably weaker in the market. IGC showed an intraday change of -9.04% in today’s session so far, and over the past year, it grew by 12.35%%.
Data on historical trading for IGC Pharma Inc (AMEX:IGC) indicates that the trading volumes over the past 10 days have averaged 12.51 and over the past 3 months, they’ve averaged 2.24 million. According to company’s latest data on outstanding shares, there are 80.88 million shares outstanding.
Nearly 31.76% of IGC Pharma Inc’s shares belong to company insiders and institutional investors own 3.41% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.53 million shares as on 2025-06-13, resulting in a short ratio of 2.25. According to the data, the short interest in IGC Pharma Inc (IGC) stood at 96.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 0.65 million. The stock has fallen by -12.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the IGC stock heading into the next quarter.
